Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study
about
"If only had I known": a qualitative study investigating a treatment of patients with a hip fracture with short time stay in hospital.Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel.Brief Report: Utilization of the First Biosimilar Infliximab Since Its Approval in South Korea.Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost.Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip FracturePrimary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.Mortality and cardiorespiratory complications in trochanteric femoral fractures: a ten year retrospective analysis.Management of hip fractures in older people in Beijing: a retrospective audit and comparison with evidence-based guidelines and practice in the UK.The burden of hip fractures - why aren't we better at prevention?Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture.
P2860
Q33647201-E69312EE-879E-48A6-ACFA-671FDD5C427AQ36095900-D648C2F9-8975-490D-A960-B956A6936F97Q36844787-A9393281-54F4-41E6-9CDF-CAFDA2920DAEQ37639402-98ED2834-CAD2-4061-B212-483C3BA56359Q38788967-40BB26B9-AA02-4F2E-B8FE-965044CB51C8Q39014377-263FAAB6-A292-40A8-B59F-C3A64BAE9D31Q39064322-0760707A-ED89-433F-A948-67E75C71291DQ39109115-97E981D5-21F9-45A0-8AA7-6FE91DEB88E9Q39117115-FC4B2C51-A14E-480C-9A3B-A89351B97A3AQ39926515-2CEC9392-EB5B-4B48-A7C2-888764ECA921Q41717921-277B6FC8-7782-4125-B940-C4604D01A9EEQ42691273-79C1BAD7-2511-446E-9159-255F02EACB2DQ45901740-2C5FA560-A75A-4AE5-9EA1-6C285BD72609Q49808666-6083EBF6-C084-4293-A16E-AC5F8C24AF31Q53469976-0DF8F6D4-F765-48DE-9958-4018FC960F2C
P2860
Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of osteoporosis medication ...... acture: a cross-national study
@ast
Use of osteoporosis medication ...... acture: a cross-national study
@en
type
label
Use of osteoporosis medication ...... acture: a cross-national study
@ast
Use of osteoporosis medication ...... acture: a cross-national study
@en
prefLabel
Use of osteoporosis medication ...... acture: a cross-national study
@ast
Use of osteoporosis medication ...... acture: a cross-national study
@en
P2093
P2860
P50
P1476
Use of osteoporosis medication ...... acture: a cross-national study
@en
P2093
Byung-Joo Park
Hong Ji Song
Jerry Avorn
Joongyub Lee
Mi-Sook Kim
Seoyoung C Kim
P2860
P304
P356
10.1016/J.AMJMED.2015.01.014
P407
P577
2015-02-03T00:00:00Z